Ticker archive · $ACTU

$ACTU Filing Signals & Market Reactions

Delayed, SEO-crawlable recaps of AI-scored catalysts for $ACTU — including observed post-filing price moves. Live streaming stays exclusive to VIP.

? All delayed signals

$ACTU

$ACTU – Actuate Therapeutics Receives Nasdaq Bid Price Deficiency Notice

ACTUATE THERAPEUTICS, INC.

2026-10-30 00:00:00 UTC · SEC_8K · All $ACTU

?? Negative AI Sentiment (-4.0 / 10)

Received Nasdaq deficiency letter after closing below $1.00 minimum bid price for 30 consecutive business days.
Compliance period ends on April 26, 2027; stock must trade at or above $1.00 for at least 10 consecutive trading days.
Potential risk of reverse stock split or delisting if compliance is not regained.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing ?

$ACTU

$ACTU – Actuate Therapeutics CEO Buys 140,844 Shares for Approx. $50,000

ACTUATE THERAPEUTICS, INC.

2026-10-29 00:00:00 UTC · SEC_FORM4 · All $ACTU

?? Positive AI Sentiment (+3.0 / 10)

Insider Daniel M Schmitt (President, CEO and Director) purchased 140,844 shares
Total transaction value estimated at $49,999.62
Purchase executed directly without a pre-set Rule 10b5-1 trading plan

Unlock Live VIP Terminal & Telegram – €10/mo Original filing ?

$ACTU

$ACTU – Actuate Therapeutics Prices $11.0M Public Offering with Accompanying Warrants

ACTUATE THERAPEUTICS, INC.

2026-10-28 00:00:00 UTC · SEC_8K · All $ACTU

?? Negative AI Sentiment (-6.5 / 10)

Offering consists of 30,985,900 common shares and 15,492,950 warrants priced at $0.71 per set
Warrants have an exercise price of $0.45 per share and 5-year expiration
Expected gross proceeds of approximately $11.0M for working capital, representing significant equity dilution

Unlock Live VIP Terminal & Telegram – €10/mo Original filing ?